Acromegalia y adenomas hipofisarios: una revision de la literatura
Open Access
- 25 October 2019
- journal article
- Published by Universidad Simon Bolivar in Ciencia e Innovación en Salud
Abstract
Acromegaly is a condition that includes certain clinical manifestations caused by high serum levels of growth hormone that, in most cases, is due to the presence of pituitary adenomas. The early clinical suspicion of this entity and its timely diagnosis allows the treatment to generate high rates of remission of the disease. Growth hormone producers account for 10 to 25%, its unspecific clinical manifestations, added to the insidious behavior of the disease, lead to a delay in its diagnosis and treatment, in such a way that the suspicion of this condition at the beginning of the appearance of signs and symptoms is relevant to decrease its morbidity.Keywords
This publication has 10 references indexed in Scilit:
- Updates in Diagnosis and Treatment of AcromegalytouchREVIEWS in Endocrinology, 2018
- Surgery for pituitary tumoursSurgery (Oxford), 2017
- Genetic Aspects of Pituitary AdenomasEndocrinology and Metabolism Clinics of North America, 2017
- Cabergoline in acromegalyPituitary, 2016
- Understanding the effect of acromegaly on the human skeletonExpert Review of Endocrinology & Metabolism, 2016
- Anatomy, Physiology, and Laboratory Evaluation of the Pituitary GlandOtolaryngologic Clinics of North America, 2016
- Silent Pituitary AdenomasEndocrinology and Metabolism Clinics of North America, 2015
- Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequencesEndocrine-Related Cancer, 2015
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority StudyThe Journal of Clinical Endocrinology & Metabolism, 2014
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of OutcomeThe Journal of Clinical Endocrinology & Metabolism, 2011